𝔖 Bobbio Scriptorium
✦   LIBER   ✦

7517 POSTER Clinical tolerability of trabectedin administered by two different schedules (weekly for 3 of 4 weeks vs q3 weeks) in patients with advanced/metastatic liposarcoma or leiomyosarcoma (L-sarcomas) progressing despite prior treatment with at least anthracycline and ifosfamide

✍ Scribed by Chawla, S.; Casali, P.G.; von Mehren, M.; Le Cesne, A.; Blay, J.Y.; Lebedinsky, C.; Alfaro, V.; Elsayed, Y.; Michiels, B.; Demetri, G.D.


Book ID
122041216
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
61 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.